Skip to search boxSkip to navigationSkip to main content

Level of tumor-infiltrating lymphocytes and density of infiltrating immune cells in different malignancies

  • Carlos A. Castaneda(corresponding author)
    ,
  • Miluska Castillo
    ,
  • Karina Aliaga
    ,
  • Luis A. Bernabe
    ,
  • Sandro Casavilca
    ,
  • Joselyn Sanchez
*Corresponding author for this work
  • ,
  • Universidad Científica del Sur
    ,
  • Instituto Nacional de Enfermedades Neoplásicas
    ,
  • The University of Texas M.D. Anderson Cancer Center
Research Output:
Contribution to journal
Article
Peer-review

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 1481-1491 (11 pages)

Journal (Volume, Issue Number)

Biomarkers in Medicine (Volume 13, Issue 17)

Publication milestones

  • Published - 2019

Publication status

Published - 2019

ISSN

1752-0363

Publication IDs

  • Scopus: 85074446280
  • PubMed: 31621387

Abstract

Aim: To correlate levels of tumor-infiltrating lymphocytes (TIL) evaluated using the International Immuno-Oncology Biomarker Working Group methodology, and both density of tumor-infiltrating immune cell and clinicopathological features in different malignancies. Methods: 209 pathological samples from gastric cancer, cervical cancer (CC), non-small-lung cancer, cutaneous melanoma (CM) and glioblastoma were tested for TIL in hematoxylin eosin, and density of CD3+, CD4+, CD8+, CD20+, CD68+ and CD163+ cells by digital analysis. Results: TIL levels were higher in invasive margin compartments (IMC). TIL in IMC, intratumoral and stromal compartments predicted survival. CC and gastric cancer had higher TIL in intratumoral; CC and CM had higher TIL in stromal compartment and IMC. CM had the highest density of lymphocyte and macrophage populations. CD20 density was associated with survival in the whole series. Conclusion: Standardized evaluation of TIL levels may provide valuable prognostic information in a spectrum of different malignancies.

Funding Details

This work was partly supported by the Programa Nacional de Innovacion para la Competitividad y Productividad-Innovate Peru (contract no. 317-PNICP-EC-2014), and CONCYTEC (contract no. 197-2015-FONDECYT). The authors have no other relevant This work was partly supported by the Programa Nacional de Innovacion para la Competitividad y Productividad-Innovate Peru (contract no. 317-PNICP-EC-2014), and CONCYTEC (contract no. 197-2015-FONDECYT). The authors have no other relevant affiliations or financialinvolvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
FundersFunding numbers
Programa Nacional de Innovacion para la Competitividad
317-PNICP-EC-2014
Programa Nacional de Innovacion para la Competitividad y Productividad-Innovate Peru
-
CONCYTEC
197-2015-FONDECYT

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Captures
36
Citations
17

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well